Virksomhedsstatus | NORMAL. |
Sidst opdateret den 09.02.2015 og
angivet som gældende fra 19.01.2001 (8620
dage). |
Ingen historik.
Branche | Engroshandel med læge- og hospitalsartikler (464620). |
Sidst opdateret den 08.02.2008 og
angivet som gældende fra 01.01.2008 (6082
dage). |
Historik | Start | Stop |
---|
Engroshandel med læge- og hospitalsartikler (464620) | 01.01.2008 | |
Fremstilling af elektrodiagnostiske apparater (331030) | 01.07.2001 | 31.12.2007 |
Engroshandel med kontormaskiner, edb-maskiner og -udstyr (516410) | 29.06.2001 | 30.06.2001 |
Uoplyst (980000) | 19.01.2001 | 28.06.2001 |
Revisionfravalgt | false. |
Sidst opdateret den 11.03.2015 og
angivet som gældende fra 19.01.2001 (8620
dage). |
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Historik | Start | Stop |
---|
33638383 | 23.08.2001 | 07.02.2002 |
Virksomheden har ikke ændret Telefon i sin
levetid. |
Ingen nuværende registrering.
Navne | BIOMÉRIEUX DENMARK ApS. |
Sidst opdateret den 13.06.2001 og
angivet som gældende fra 12.06.2001 (8476
dage). |
Historik | Start | Stop |
---|
BIOMÉRIEUX DENMARK ApS | 12.06.2001 | |
GFKJUS 623 ApS | 19.01.2001 | 11.06.2001 |
Tegningsregel | Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af en direktør. |
Sidst opdateret den 09.02.2015 og
angivet som gældende fra 29.04.2014 (3772
dage). |
Fortolkning
(2 tegningsmuligheder)
| 2 bestyrelsesmedlemmer + |
1 direktør |
Ingen historik.
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:EY Godkendt Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:30700228
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (ISAs) and additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Independence
We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code.
Konklusion (revision):Opinion
We have audited the financial statements of BIOMERIEUX DENMARK ApS for the financial year 1 January - 31 December 2023, which comprise accounting policies, income statement, balance sheet, statement of changes in equity and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.
In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2023 and of the results of the Company's operations for the financial year 1 January - 31 December 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on the Management's review
Management is responsible for the Management's review.
Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act.
Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of the Management's review.
,
Management is responsible for the Management's review.
Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act.
Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of the Management's review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.